A Phase 3, Long-term, Open-label Study of Istradefylline

Project: Research project

Project Details

Description

A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects with Moderate to Severe Parkinson's Disease
StatusFinished
Effective start/end date12/1/1511/30/18

Funding

  • KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.